|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.22 EUR | -5.97% |
|
+1.69% | +151.09% |
| 07-03 | Genfit soars on news of U.S. reimbursement for a product |  |
| 07-03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
| Market Cap | 661M 754M 614M 564M 1.06B 72.87B 1.08B 7.32B 2.86B 35.6B 2.83B 2.77B 123B | P/E 2026 * |
69.5x | P/E 2027 * | 87.8x |
|---|---|---|---|---|---|
| Enterprise Value | 610M 696M 567M 521M 980M 67.24B 996M 6.75B 2.64B 32.85B 2.61B 2.56B 114B | EV / Sales 2026 * |
6.09x | EV / Sales 2027 * | 4.8x |
| Free-Float |
86.88% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -5.97% | ||
| 1 week | +1.69% | ||
| Current month | +24.72% | ||
| 1 month | +24.02% | ||
| 3 months | +48.54% | ||
| 6 months | +151.09% | ||
| Current year | +151.09% |
| 1 week | 12.34 |  | 14.16 |
| 1 month | 9 | | 14.32 |
| Current year | 5.05 | | 14.32 |
| 1 year | 3.05 | | 14.32 |
| 3 years | 2.62 | | 14.32 |
| 5 years | 2.62 | | 14.32 |
| 10 years | 2.62 | | 35.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 2019-09-15 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 2021-04-21 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 2025-11-26 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 2017-06-15 | |
| Director/Board Member | 54 | 1999-09-14 | |
| Director/Board Member | 58 | 2017-06-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/5/26 | Fiscal year | Chief Operating Officer | 11,250 | 0.0225% | ||
| 3/5/26 | Sell | Chief Operating Officer | 7,083 | 0.0142% | ||
| 3/5/26 | Fiscal year | Chief Operating Officer | 10,625 | 0.0212% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.97% | +1.69% | +298.19% | +266.20% | 802M | |
| -4.89% | -7.90% | -4.49% | +9.27% | 48.5B | |
| -0.14% | -1.05% | +376.39% | +583.71% | 38.97B | |
| +0.39% | +4.36% | +9.59% | +61.99% | 35.43B | |
| -1.54% | -4.48% | +24.89% | -13.03% | 33.65B | |
| -0.87% | -1.56% | -1.43% | +29.16% | 26.58B | |
| -1.28% | -5.14% | - | - | 16.82B | |
| -0.67% | -1.50% | +70.98% | +115.31% | 15.18B | |
| +1.32% | +2.29% | +14.62% | +15.52% | 13.89B | |
| +0.40% | -0.41% | +19.80% | -31.98% | 12.76B | |
| Average | +0.48% | -0.27% | +89.84% | +115.13% | 24.26B | |
| Weighted average by Cap. | -0.17% | -1.25% | +76.90% | +121.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 100M 114M 93.1M 85.48M 161M 11.04B 163M 1.11B 433M 5.39B 429M 420M 18.64B | 124M 142M 115M 106M 199M 13.67B 202M 1.37B 536M 6.68B 531M 520M 23.08B |
| Net income | 22.88M 26.1M 21.26M 19.52M 36.75M 2.52B 37.33M 253M 98.94M 1.23B 97.97M 95.85M 4.26B | 6.8M 7.76M 6.32M 5.8M 10.92M 749M 11.1M 75.27M 29.41M 366M 29.12M 28.49M 1.27B |
| Net Debt | -51.12M -58.32M -47.5M -43.61M -82.11M -5.63B -83.41M -566M -221M -2.75B -219M -214M -9.51B | -66.17M -75.49M -61.49M -56.45M -106M -7.29B -108M -732M -286M -3.56B -283M -277M -12.31B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-22 | €13.22 | -5.97% | 511,858 |
| 26-07-21 | €14.06 | +3.69% | 463,717 |
| 26-07-20 | €13.56 | +5.12% | 393,303 |
| 26-07-17 | €12.90 | -0.77% | 264,455 |
| 26-07-16 | €13.00 | -4.41% | 322,872 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GNFT Stock
Select your edition
All financial news and data tailored to specific country editions
